Human & Experimental Toxicology,
Journal Year:
2024,
Volume and Issue:
43
Published: Jan. 1, 2024
Introduction
Organophosphate
pesticides
(Ops)
like
diazinon
(DZN)
have
well-known
neurotoxic
effects
and
low-level
chronic
exposure
has
been
linked
to
detrimental
neurobehavioral
impairments
memory
deficits.
However,
it’s
not
entirely
clear
how
DZN-induced
biological
changes,
particularly
in
the
prefrontal
cortex
(PFC)
contribute
these
effects.
The
purpose
of
this
study
is
investigate
impact
DZN
on
inhibitory
avoidance
(IA)
function,
amyloid
precursor
expression
(APP),
proinflammatory
tumor
necrosis
factor-α
(TNF-α)
levels
rat
cortex.
Materials
Methods
Rats
were
divided
into
4
groups
recived
2
mg/kg
for
5-days
or
12-weeks
two
control
same
volume
vehicle.
IA
was
assesed
using
shuttle
box
apparatus.
sacrificed
PFC
removed.
Real-time
PCR
Western
blotting
used
messure
TNF-α,
protein
precursors
gene
levels.
Results
Our
findings
indicated
that
caused
body
weight
loss
a
notable
decline
performance
memory.
Additionally,
increased
APP
APLP2
PFC,
while
decreased
Furthermore,
gens
PFC.
TNF-α
as
result
DZN,
but
dropped
normal
after
administration,
observation
significant.
Conclusion
Taken
together,
low
doses
leads
disturbances
also
alternations
beta
can
be
related
risk
Alzheimer’s
disease.
Biomolecules,
Journal Year:
2022,
Volume and Issue:
12(3), P. 371 - 371
Published: Feb. 25, 2022
Alzheimer’s
and
Parkinson’s
diseases
are
the
two
most
common
forms
of
neurodegenerative
diseases.
The
exact
etiology
these
disorders
is
not
well
known;
however,
environmental,
molecular,
genetic
influences
play
a
major
role
in
pathogenesis
Using
disease
(AD)
as
archetype,
pathological
findings
include
aggregation
Amyloid
Beta
(Aβ)
peptides,
mitochondrial
dysfunction,
synaptic
degradation
caused
by
inflammation,
elevated
reactive
oxygen
species
(ROS),
cerebrovascular
dysregulation.
This
review
highlights
neuroinflammatory
neuroprotective
epigallocatechin-3-gallate
(EGCG):
medicinal
component
green
tea,
known
nutraceutical
that
has
shown
promise
modulating
AD
progression
due
to
its
antioxidant,
anti-inflammatory,
anti-aging
abilities.
report
also
re-examines
current
literature
provides
innovative
approaches
for
EGCG
be
used
preventive
measure
alleviate
other
disorders.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(4), P. 1630 - 1630
Published: Feb. 17, 2023
Due
to
the
key
role
of
tumor
necrosis
factor-alpha
(TNF-α)
in
pathogenesis
immunoinflammatory
diseases,
TNF-α
inhibitors
have
been
successfully
developed
and
used
clinical
treatment
autoimmune
disorders.
Currently,
five
anti-TNF-α
drugs
approved:
infliximab,
adalimumab,
golimumab,
certolizumab
pegol
etanercept.
Anti-TNF-α
biosimilars
are
also
available
for
use.
Here,
we
will
review
historical
development
as
well
present
potential
future
applications
therapies,
which
led
major
improvements
patients
with
several
such
rheumatoid
arthritis
(RA),
ankylosing
spondylitis
(AS),
Crohn’s
disease
(CD),
ulcerative
colitis
(UC),
psoriasis
(PS)
chronic
endogenous
uveitis.
Other
therapeutic
areas
under
evaluation,
including
viral
infections,
e.g.,
COVID-19,
neuropsychiatric
disorders
certain
forms
cancer.
The
search
biomarkers
able
predict
responsiveness
is
discussed.
Brain Pathology,
Journal Year:
2022,
Volume and Issue:
32(6)
Published: March 14, 2022
Abstract
Cerebrovascular
disease
underpins
vascular
dementia
(VaD),
but
structural
and
functional
changes
to
the
cerebral
vasculature
contribute
pathology
cognitive
decline
in
Alzheimer's
(AD).
In
this
review,
we
discuss
contribution
of
amyloid
angiopathy
non‐amyloid
small
vessel
AD,
accompanying
density,
maintenance
remodelling
vessels
(including
alterations
composition
function
cerebrovascular
basement
membrane).
We
consider
how
abnormalities
constituent
cells
neurovascular
unit
–
particularly
endothelial
pericytes
impairment
blood‐brain
barrier
(BBB)
impact
on
pathogenesis
AD.
also
are
likely
impair
Aβ
clearance
both
intra‐periarteriolar
drainage
(IPAD)
transport
peptides
across
BBB,
impaired
coupling
reduced
blood
flow
relation
metabolic
demand
increase
amyloidogenic
processing
APP
production
Aβ.
review
vasoactive
properties
themselves,
probable
bi‐directional
relationship
between
dysfunction
accumulation
Lastly,
recent
methodological
advances
transcriptomics
imaging
that
have
provided
novel
insights
into
assessment
retina
allow
vivo
detection
early
stages
Neuronal Signaling,
Journal Year:
2023,
Volume and Issue:
7(2)
Published: June 26, 2023
Abstract
There
are
several
hypotheses
concerning
the
underlying
pathophysiological
mechanisms
of
major
depression,
which
centre
largely
around
adaptive
changes
in
neuronal
transmission
and
plasticity,
neurogenesis,
circuit
regional
connectivity.
The
immune
endocrine
systems
commonly
implicated
driving
these
changes.
An
intricate
interaction
stress
hormones,
innate
cells
actions
soluble
mediators
immunity
within
nervous
system
is
described
as
being
associated
with
symptoms
depression.
Bridging
processes
to
neurotransmission
signalling
key
cortical
limbic
brain
circuits
critical
understanding
depression
a
disorder
neuroimmune
origins.
Emergent
areas
research
include
growing
recognition
system,
advances
neuroimaging
techniques
mechanistic
insights
gained
from
transgenic
animals.
Elucidation
glial–neuronal
interactions
providing
additional
avenues
into
promising
research,
development
clinically
relevant
disease
models
discovery
novel
therapies.
This
narrative
review
focuses
on
molecular
cellular
that
influenced
by
inflammation
stress.
aim
this
provide
an
overview
our
current
origin,
focusing
neuroendocrine
dysregulation
pathophysiology.
Advances
lie
pursuit
biomarkers,
potential
biomarker
signatures
improve
clinical
outcomes
yet
be
fully
realised.
Further
investigations
expand
panels
including
integration
neuroimaging,
utilising
individual
stratify
patients
more
homogenous
subpopulations
targeting
for
new
treatment
approaches
will
help
address
unmet
need.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(11), P. 5803 - 5803
Published: May 26, 2024
The
neuroimmune
system
is
a
collection
of
immune
cells,
cytokines,
and
the
glymphatic
that
plays
pivotal
role
in
pathogenesis
progression
Alzheimer’s
disease
(AD).
Of
particular
focus
are
group
signaling
molecules
facilitate
communication
among
cells
contribute
to
inflammation
AD.
Extensive
research
has
shown
dysregulated
secretion
certain
cytokines
(IL-1β,
IL-17,
IL-12,
IL-23,
IL-6,
TNF-α)
promotes
neuroinflammation
exacerbates
neuronal
damage
However,
anti-inflammatory
(IL-2,
IL-3,
IL-33,
IL-35)
also
secreted
during
AD
onset
progression,
thereby
preventing
neuroinflammation.
This
review
summarizes
involvement
pro-
pathology
discusses
their
therapeutic
potential.
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: Jan. 23, 2024
Abstract
Parkinson’s
disease
(PD)
and
Alzheimer’s
(AD)
are
neurodegenerative
disorders
caused
by
the
interaction
of
genetic,
environmental,
familial
factors.
These
diseases
have
distinct
pathologies
symptoms
that
linked
to
specific
cell
populations
in
brain.
Notably,
immune
system
has
been
implicated
both
diseases,
with
a
particular
focus
on
dysfunction
microglia,
brain’s
resident
cells,
contributing
neuronal
loss
exacerbating
symptoms.
Researchers
use
models
neuroimmune
gain
deeper
understanding
physiological
biological
aspects
these
how
they
progress.
Several
vitro
vivo
models,
including
2D
cultures
animal
utilized.
Recently,
advancements
made
optimizing
existing
developing
3D
organ-on-a-chip
systems,
holding
tremendous
promise
accurately
mimicking
intricate
intracellular
environment.
As
result,
represent
crucial
breakthrough
transformation
current
treatments
for
PD
AD
offering
potential
conducting
long-term
disease-based
modeling
therapeutic
testing,
reducing
reliance
significantly
improving
viability
compared
conventional
models.
The
application
research
marks
prosperous
step
forward,
providing
more
realistic
representation
complex
interactions
within
system.
Ultimately,
refined
aim
aid
quest
combat
mitigate
impact
debilitating
patients
their
families.
Theranostics,
Journal Year:
2021,
Volume and Issue:
11(19), P. 9452 - 9469
Published: Jan. 1, 2021
Background:
Neuronal
death
is
a
major
hallmark
of
Alzheimer's
disease
(AD).
Necroptosis,
as
programmed
necrotic
process,
activated
in
AD.
However,
what
signals
and
factors
initiate
necroptosis
AD
largely
unknown.
Methods:
We
examined
the
expression
levels
critical
molecules
necroptotic
signaling
pathway
by
immunohistochemistry
(IHC)
staining
immunoblotting
using
brain
tissues
from
patients
mouse
models
APP/PS1
5×FAD.
performed
stereotaxic
injection
with
recombinant
TNF-α,
anti-TNFR1
neutralizing
antibody
or
AAV-mediated
gene
knockdown
mice.
For
vitro
studies,
we
used
TNF-α
combined
zVAD-fmk
Smac
mimetic
to
establish
neuronal
utilized
pharmacological
molecular
biological
approaches
study
pathways.
Results:
find
that
dependent
on
upstream
TNF-α/TNFR1
both
cell
cultures
models.
Upon
stimulation,
accumulated
p62
recruits
RIPK1
induces
its
self-oligomerization,
activates
downstream
RIPK1/RIPK3/MLKL
cascade,
leading
necroptosis.
Ectopic
accumulation
caused
impaired
autophagy
flux,
which
mediated
UVRAG
downregulation
during
TNF-α-promoted
Notably,
overexpression
inhibits
Conclusions:
identify
finely
controlled
regulation
coordinated
signaling,
RIPK1/3
activity
machinery.
Strategies
could
fine-tune
may
bring
promising
therapeutics
for
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(5), P. 923 - 923
Published: May 8, 2022
The
heme
oxygenase
(HO)
system
is
believed
to
be
a
crucial
mechanism
for
the
nervous
under
stress
conditions.
HO
degrades
carbon
monoxide,
iron,
and
biliverdin.
These
degradation
products
are
involved
in
modulating
cellular
redox
homeostasis.
first
identified
isoform
of
system,
HO-1,
an
inducible
protein
that
highly
expressed
peripheral
organs
barely
detectable
brain
normal
conditions,
whereas
HO-2
constitutive
brain.
Several
lines
evidence
indicate
HO-1
dysregulation
associated
with
inflammation
neurodegeneration,
including
Parkinson’s
Alzheimer’s
diseases.
In
this
review,
we
summarize
essential
roles
plays
ensuring
health
molecular
through
which
dysfunction
leads
neurodegenerative
diseases
disruption
We
also
provide
summary
herbal
medicines
regulation
expression
explore
current
situation
regarding
remedies
disorders.
Current Research in Pharmacology and Drug Discovery,
Journal Year:
2022,
Volume and Issue:
4, P. 100149 - 100149
Published: Dec. 20, 2022
Neurodegeneration
and
synaptic
loss
in
Alzheimer's
disease
(AD)
lead
to
impairment
memory
functions.
Neuroinflammation
causes
activation
of
microglia
astrocytes
cells
that
locally
systemically
produces
inflammatory
cytokines
which
can
serve
as
early
diagnostic
markers
or
therapeutic
targets
AD.
Pro-inflammatory
(Interleukins
(IL-1β,
IL-6
IL-10)
tumor
necrosis
factor
(TNF
α))
levels
were
estimated
serum,
cerebral
tissue,
hepatic
renal
tissue
treatment
groups
scopolamine-induced
amnesia
mice
model
using
ELISA
protocol.
The
results
showed
AD
exhibited
elevated
IL1β,
IL6,
IL10
TNFα
indicate
contribution
pro-inflammatory
the
progression
A
significant
reduction
concentration
IL-10
TNF-α
noticed
animal
group
treated
with
marketed
memantine
tablet
(Admenta),
pure
drug
(MEMp),
memantine-poly
(lactic-co-glycolic
acid)
self-assembled
nanoscaffolds
(MEM-PLGA)
SANs,
Polyethylene
Glycol
coated
[(PEG-MEM-PLGA)
SANs]
[(lactic-co-glycolic
acid)]
grafted
Bone
Marrow
Derived
Stem
Cell
((PEG-MEM-PLGA)
SANs-BMSc),
whereas
a
high
level
was
observed
tissues
normal
induced
emerging
potential
trigger
either
neurons
survival
after
injury
causing
neurodegeneration
cell
apoptosis.
Neuroregenerative
stem
helps
proliferation
neuronal
thus
improves
cognition
model.